Neuroprotective Effects of Inflammation in the Nervous System

NeuroImmune Biology

Volumn 6, Issue C, 2008, Pages 403-431

  Correale, Jorge ^a   Fiol, Marcela ^a   Villa, Andrés ^b  

^a FLENI

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77957786503     PISSN: 15677443     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1567-7443(07)10020-X     Document Type: Review

References (223)

1. Antel J., Birbbaum G., and Hartung HP. Clinical Neuroimmunology (1998), Blackwell Science, Oxford
2. Immunology and Infectious Diseases of the Peripheral Nerves. In: Latov N., Wokke J.H.J., and Kelly Jr. J.J. (Eds) (1998), Cambridge University Press, New York
3. Antel J.P., and Becher B. Central nervous system-immune interactions: Contribution to neurologic disease and recovery. In: Antel J., Birbbaum G., and Hartung HP E. (Eds). In Clinical Neuroimmunology (1998), Blackwell Science, Oxford 26-39
4. Pachter J.S., de Vries H.E., and Fabry Z. The blood-brain barrier and its role in immune privilege in the central nervous system. J Neuropathol Exp Neurol 62 (2003) 593-604
5. Becher B., and Antel JP. Comparison of phenotypic and functional properties of immediately ex vivo and cultured human adult microglia. Glia 18 (1996) 1-10
6. Williams K., Ulvestad E., and Antel JP. B7/BB-1 antigen expression on adult microglia studied in vitro and in situ. Eur J Immunol 24 (1994) 3031-3037
7. Windhangen A., Newcombe J., Dangond F., Strand C., Woodroofe M.N.B., Cuzner M.L., and Hafler DA. Expression of costimulatory molecules B7-1 (CD80), B7-2 (CD86), and interleukin 12 cytokine in multiple sclerosis lesions. J Exp Med 182 (1995) 1985-1996
8. Aloisi F., Ria F., Penna G., and Adorini L. Microglia are more efficient than astrocytes in antigen processing and in Th1 but not Th2 cell activation. J Immunol 160 (1998) 4671-4680
9. Aloisi F., Penna G., Polazzi E., Minghetti L., and Adorini L. CD40-CD154 interaction and IFN-gamma are required for IL-12 but not prostaglandin E2 secretion by microglia during antigen presentation to Th1 cells. J Immunol 162 (1999) 1384-1391
10. Fontana A., Fierz F., and Wekerle H. Astrocytes present myelin basic protein to encephalitogenic T-cell lines. Nature 307 (1994) 273-276
11. Massa PT t., Meulen V., and Fontana A. Hyperinducibility of Ia antigen on astrocytes correlates with strain-specific susceptibility to experimental autoimmune encephalomyelitis. Proc Natl Acad Sci USA 84 (1987) 4219-4223
12. Sedgwick J.D., Mossner R., Schwender S., and ter Meulen V. Major histocompatibility complex-expressing nonhematopoietic astroglial cells prime only CD8+ T lymphocytes: Astroglial cells as perpetuators but not initiators of CD4+ T cell responses in the central nervous system. J Exp Med 173 (1991) 1235-1246
13. Matsumoto Y., Ohmori K., and Fujiwara M. Immune regulation by brain cells in the central nervous system by microglia but not astrocytes present myelin basic protein to encephalitogenic T cells under in vivo-mimicking conditions. Immunology 76 (1992) 209-216
14. Weber F., Meinl E., Aloisi F., Nevinny-Stickel C., Albert E., Wekerle H., and Holhfeld R. Human astrocytes are only partially competent antigen presenting cells. Possible implications for lesion development in multiple sclerosis. Brain 117 (2004) 59-69
15. Koski CL. Immune interactions in the peripheral nervous system. In: Latov N., Wokke J.H.J., and Kelly Jr. J.J. (Eds). In Immunology and Infectious Diseases of the Peripheral Nerves (1998), Cambridge University Press, New York 1-28
16. Friedman B., Scherer S.S., Rudge J.S., Helgren M., Morriscy D., McIain J., Wang D.Y., Wiegand S.J., Furth M.E., and Lindsay RM. Regulation of ciliary neurotrophic factor expression in myelin-related Schwann cells in vivo. Neuron 9 (1992) 295-305
17. Henderson C.E., Phillips H.S., Pollock R.A., Davies A.M., Lemeulle C., Armanini M., Simpson L.C., MoVet B., Vandlen R.A., Koliatsos V.E., and Rosenthal A.G. A potent survival factor for motoneurons present in peripheral nerve and muscle. Science 266 (1994) 1062-1064
18. Yamamoto M., Sobue G., Li M., Arakawa Y., Mitsuma T., and Kimata K. Nerve growth factor (NGF), brain derived neurotrophic factor (BDNF) and low-affinity nerve growth factor receptor (LNGFR) mRNA levels in cultures rat Schwann cells; differential time-and-dose-dependent regulation by cAMP. Neurosci Lett 152 (1993) 37-40
19. Mancardi G.L., Cadoni A., Zicca A., Schenone A., Tabaton A D., Martin A., and Zaccheo D. HLA-DR Schwann cell reactivity in peripheral neuropathies of different origins. Neurology 38 (1988) 848-851
20. Pollard J.D., Baverstocl J., and McLeod JG. Class II antigen expression and inflammatory cells in the Guillain-Barre syndrome. Ann Neurol 21 (1987) 337-341
21. Armati P.J., Pollard J.D., and Gatenby P. Rat and human Schwann cells in vitro can synthesize and express MHC molecules. Muscle Nerve 13 (1990) 106-116
22. Gold T., Toyka K.V., and Hartung HP. Synergistic effect of IFN-gamma and TNF-alpha on expression of immune molecules and antigen presentation by Schwann cells. Cell Immunol 165 (1995) 65-70
23. Lilje O., and Armati PJ. The distribution and abundance of MHC and ICAM-1 on Schwann cells in vitro. J Neuroimmunol 77 (1997) 75-84
24. Cowley S.A., Butter C., Gschmeissner S.E., Curtis J., and Turk JL. An immunoelectromicroscopical study of the expression of major histocompatibility complex (MHC) class II antigens in guinea pig sciatic nerves following induction of intraneural mycobacterial granulomas. J Neuroimmunol 23 (1989) 223-231
25. Griffin J.W., Stoll G., Li C.Y., Tyor W., and Cornblath DR. Macrophage responses in demyelinating neuropathies. Ann Neurol 27 (1990) S64-S68
26. Schmidt B., Stoll G., Hartung H.P., Heininger K., Schafer B., and Toyka KV. Macrophages but not Schwann cells express Ia antigen in experimental allergic neuritis. Ann Neurol 28 (1990) 70-77
27. Chaudhry V., Glass J.D., and Griffin JW. Wallerian degeneration in peripheral nerve disease. Neurol Clin 10 (1992) 613-627
28. Brück W., Huitinga I., and Dijkstra CD. Liposome-mediated monocyte depletion during Wallerian degeneration defines the role of hematogenous phagocytes in myelin removal. J Neurosci Res 46 (1996) 477-484
29. Creange A., Barlovatz-Meimon G., and Gherardi RK. Cytokines and peripheral nerve disorders. Eur Cytokine Netw 8 (1997) 145-151
30. Fernández-Valle C., Bunge R.P., and Bunge MB. Schwann cells degrade myelin and proliferate in the absence of macrophages: evidence from in vitro studies of Wallerian degeneration. J Neurocytol 24 (1995) 667-679
31. Shamash S., Reichert F., and Rotshenker S. The cytokine network of Wallerian degeneration: Tumor necrosis factor-α, and interleukin-1β. J Neurosci 22 (2002) 3052-3060
32. Allan S.M., and Rothwell NJ. Cytokines and acute neurodegeneration. Nat Rev Neurosci 2 (2001) 734-744
33. Nguyen M.D., and Rivest S. Innate immunity: The missing link in neuroprotection and neurodegeneration?. Nat Rev Neurosci 3 (2002) 216-227
34. Profyris C., Cheema S.S., Zang D.W., Azari M.F., Boyle K., and Petratos S. Degenerative and regenerative mechanisms governing spinal cord injury. Neurobiol Dis 15 (2004) 415-436
35. Iadecola C., Niwa K., Nogawa S., Zhao X., Nagayama M., Araki E., Morham S., and Ross ME. Reduced susceptibility to ischemic brain injury and N-methyl-d-aspartate-mediated neurotoxicity in cyclooxygenase-2-deficient mice. Proc Natl Acad Sci 98 (2001) 1294-1299
36. Soriano S.G., Lipton S.A., Wang Y.F., Xiao M., Springer T.A., Gutierrez-Ramos J.C., and Hickey PR. Intercellular adhesion molecules-1-deficient mice are less susceptible to cerebral ischemia-reperfusion injury. Ann Neurol 39 (1996) 618-624
37. Boutin H., LeFeuvre R.A., Horai R., Asano M., Iwakura Y., and Rothwell NJ. Role of IL-1 alpha and IL-1 beta in ischemic brain damage. J Neurosci 21 (2001) 5528-5534
38. Passinetti GM. Cyclooxygenase and inflammation in Alzheimer's disease: Experimental approaches and clinical interventions. J Neurosci Res 54 (1998) 1-6
39. Gonzalez-Scarano F., and Baltuch G. Microglia as mediators of inflammatory and degenerative diseases. Annu Rev Neurosci 22 (1999) 219-240
40. Julien JP. Amyotrophic lateral sclerosis: Unfolding the toxicity of the misfolded. Cell 104 (2001) 581-591
41. David S., and Aguayo AJ. Axonal elongation into peripheral nervous system "bridges" after central nervous system injury in adult rats. Science 214 (1981) 931-933
42. David S., and Aguayo AJ. Axonal regeneration after crush injury in rat central nervous system fibers innervating peripheral nerve grafts. J Neurocytol 14 (1985) 1-12
43. David S., Bouchard C., Tsatas O., and Giftochristos N. Macrophages can modify the nonpermissive nature of the adult mammalian central nervous system. Neuron 5 (1990) 463-469
44. Iseda T., Nishio T., Kawaguchi S., Yamanoto M., Kawasaki T., and Wakisaka S. Spontaneous regeneration of the corticospinal tract after transection in young rats: A key role of reactive astrocytes in making favourable and unfavourable conditions for regeneration. Neuroscience 126 (2004) 365-374
45. Kawaja M.D., and Gage FH. Reactive astrocytes are substrate for the growth of adult CNS axons in the presence of elevated levels of nerve growth factors. Neuron 7 (1991) 1019-1030
46. George R., and Griffin JW. Delayed macrophage responses and myelin clearance during Wallerian degeneration in the central nervous system: The dorsal radiculotomy model. Exp Neurol 129 (1994) 225-236
47. Perry V.H., and Brown M.C. Gordon S The macrophage response to central and peripheral injury: A possible role for macrophages in regeneration. J Exp Med 165 (1987) 1218-1223
48. Stoll G., Griffin J.W., Li C.Y., and Trapp BD. Wallerian degeneration in the peripheral nervous system: Participation of both Schwann cells and macrophages in myelin degradation. J Neurocytol 18 (1989) 671-683
49. Chen M.S., Huber A.B., van der Haar M.E., Frank M., Scnell L., Spillman A.A., Christ F., and Schwab ME. Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1. Nature 403 (2000) 434-439
50. Mukhopadhyay G., Doherty P., Walsh F.S., Crocker P.R., and Filbin MT. A novel role for myelin-associated glycoprotein as an inhibitor of axonal regeneration. Neuron 13 (1994) 757-767
51. Krakowski M., and Owens T. Interferon-gamma confers resistance to experimental allergic encephalomyelitis. Eur J Immunol 26 (1996) 1641-1646
52. Zeev-Brann A.B., Lazarov-Spiegler O., Brenner T., and Schwartz M. Differential effects of central and peripheral nerves on macrophages and microglia. Glia 23 (1998) 181-190
53. Lazarov-Spiegeler O., Salomon A.S., Zeev-Brann A.B., Hirschberg D.L., Lavie V., and Schwartz M. Transplantation of activated macrophages overcomes central nervous system regrowth failure. FASEB J 10 (1996) 1296-1302
54. Lazarov-Spiegeler O., Salomon A.S., and Schwartz M. Peripheral nerve-stimulated macrophages simulate a peripheral nerve-like regenerative response in rat transected optic nerve. Glia 24 (1998) 329-337
55. Rapalino O., Lazarov-Spiegeler O., Agranov E., Velan G.J., Yoles E., Fraidakis M., Solomon A., Gepstein R., Katz A., Belkin M., Hadani M., and Schwartz M. Implantation of stimulated homologous macrophages results in partial recovery of paraplegic rats. Nat Med 4 (1998) 814-821
56. Kotter M.R., Setzu A., Sim FJ V., Rooijen N., and Franklin RJM. Macrophage depletion impairs oligodendrocyte remyelination following lysolecithin-induced demyelination. Glia 35 (2001) 204-212
57. Ousman S.S., and David S. Lysophosphatidylcholine induces rapid recruitment and activation of macrophages in the adult mouse spinal cord. Glia 30 (2000) 92-104
58. Rabchensky A.G., and Streitt WJ. Grafting of cultured microglia cells into the lesioned spinal cord of adult rats enhances neurite outgrowth. J Neurosci Res 47 (1997) 34-48
59. Robinson S., and Miller RH. Contact with central nervous system myelin inhibits oligodendrocyte progenitor maturation. Dev Biol 216 (1999) 359-368
60. Shields S.A., Gilson J.M., Blakemore W.F., and Franklin RJM. Remyelination occurs as extensively but more slowly in old rats compared to young rats following gliotoxin-induced CNS demyelination. Glia 28 (1999) 77-83
61. Masson J.L., Jones J.J., Taniike M., Morelll P., Suzuki K., and Matsushima GK. Mature oligodendrocytes apoptosis precedes IGF-I production and oligodendrocyte progenitor accumulation and differentiation during demyelination/remyelination. J Neurosci Res 61 (2000) 251-262
62. Woodruff R.H., and Franklin RJM. The expression of myelin protein mRNAs during remyelination of lysolecithin-induced demyelination. Neuropathol Appl Neurobiol 25 (1999) 226-235
63. Asakura K., and Rodriguez M. A unique population of circulating autoantibodies promotes central nervous system remyelination. Mult Scler 4 (1998) 217-221
64. Giulian D., Baker T.J., Shih L.C., and Lachman LB. Interleukin 1 of the central nervous system is produced by amoeboid microglia. J Exp Med 164 (1986) 594-604
65. Giulian D., Woodward J., Young D.G., Krebs J.F., and Lachman LB. Interleukin-1 injected into mammalian brain stimulates astrogliosis and neovascularization. J Neurosci 8 (1988) 2485-2490
66. Aloisi F., Borsellino G., Samoggia P., Testa U., Chelucci C., Russo G., Peschle C., and Levi G. Astrocyte cultures from human embryonic brain: Characterization and modulation of surface molecules by inflammatory cytokines. J Neurosci Res 32 (1992) 494-506
67. Deller T., Haas C.A., Naumann T., Joester A., Faissner A., and Frotscher M. Up-regulation of astrocyte-derived tenascin-C correlates with neurite outgrowth in the rat dentate gyrus after unilateral enthorinal cortex lesion. Neuroscience 81 (1997) 829-846
68. Poulsen F.R., Lagord C., Courty J., Pedersen E.B., Barritault D., and Finsen B. Increased synthesis of heparin affin regulatory peptide in the perforant path lesioned mouse hippocampal formation. Exp Brain Res 135 (2000) 319-330
69. Asada H., Ip N.Y., Pan L., Razack N., Parfitt M.M., and Plunkett RJ. Time course of ciliary neurotrophic factor mRNA expression is coincident with the presence of protoplasmic astrocytes in traumatized rat striatum. J Neurosci Res 40 (1995) 22-30
70. Hagg T., and Varon S. Ciliary neurotrophic factor prevents degeneration of adult rats substantia nigra dopaminergic neurons in vivo. Proc Natl Acad Sci 90 (1993) 6315-6319
71. Ho A., and Blum M. Regulation of astroglial-derived dopaminergic neurotrophic factors by interleukin-1beta in striatum of young and middle-aged mice. Exp Neurol (1997) 148
72. Haga S., Akai K., and Ishii T. Demonstration of microglial cells in and around senile (neuritic) plaques in the Alzheimer brain. An immunohistochemical study using a novel monoclonal antibody. Acta Neuropathol (Berl) 77 (1989) 569-575
73. Wegiel J., Imaki H., Wang K.C., and Rubenstein R. Cells of monocyte/microglial lineage are involved in both microvessel amyloidosis and fibrillar plaque formation in APPsw tg mice. Brain Res 1022 (2004) 19-29
74. Bianca V.D., Dusi S., Bainchini E D., Pra I., and Rossi F. oβ-Amyloid activates the O2 forming NADPH oxidase in microglia, monocytes and neutrophils. A possible mechanism of neuronal damage in Alzheimer's disease. J Biol Chem 274 (1999) 15493-15499
75. Heneka M., Heneka M.T., Loschmann P.A., Gleichmann M., Weller M., Schulz J.B., Wullner U., and Klockgether T. Induction of nitric oxide synthase and nitric-oxide-mediated apoptosis in neuronal PC12 cells after stimulation with tumor necrosis factor-α/lipopolysaccharide. J Neurochem 71 (1998) 88-94
76. Siamrd A.R., and Rivest S. Neuroprotective properties of the innate immune system and bone marrow stem cells in Alzheimer's disease. Mol Psychiatry 11 (2006) 327-335
77. Wegiel J., Imaki H., Wang K.C., Wronsca A., Osuchowski M., and Rubenstein R. Origin and turnover of microglial cells in fibrillar plaques of APPsw transgenic mice. Acta Neuropathol (Berl) 105 (2003) 393-402
78. Turrin N., and Rivest S. Tumor necrosis factor α but not interleukin 1β mediates neuroprotection in response to acute nitric oxide excitotoxicity. J Neurosci 26 (2006) 143-151
79. Weiner H.L., and Frenkel D. Immunology and immunotherapy of Alzheimer's disease. Nat Rev Immunol 6 (2006) 404-416
80. Masliah E., Hansen L., Adame A., Crews L., Bard F., Lee C., Seubert P., Games D., Kirby L., and Schenk D. Aβ vaccination effects on plaque pathology in the absence of encephalitis in Alzheimer disease. Neurology 64 (2005) 129-131
81. Paresce D.M., Ghosh R.N., and Maxfiled FR. Microglial cells internalize aggregates of the Alzheimer's disease amyloid β-protein via a scavenger receptor. Neuron 17 (1996) 553-565
82. Giulian D., Haverkamp L.J., Yu J., Karshin W., Tom D., Li J., Kazanskaia A., Kirkpatrick J., and Roher AE. The HHQK domain of β-amyloid provides a structural basis for the immunopathology of Alzheimer's disease. J Biol Chem 273 (1998) 29719-29726
83. Xie L., Helmerhorst E., Taddei K., Plewright B V., Bronswijk W., and Martins R. Alzheimer's β-amyloid peptides compete for insulin binding to the insulin receptor. J Neurosci 22 (2002) RC221
84. Qiu W.Q., Walsh D.M., Ye Z., Vekrellis K., Zhang J., Podlisny M.B., Rosner M.R., Safavi A., Hersh L.B., and Selkoe DJ. Insulin-degrading enzyme regulates extracellular levels of amyloid-β protein by degradation. J Biol Chem 273 (1998) 32730-32738
85. Prineas J.W., and McLeod JG. Chronic relapsing polyneuritis. J Neurol Sci 27 (1976) 427-458
86. Prineas JW. Pathology of Guillain-Barre syndrome. Ann Neurol 9 Suppl (1981) 6-19
87. Griffin J.W., Li C.Y., Ho T.W., Tian M., Gao C.Y., Xue P., Mishu B., Cornblath D.R., Macko C., McKhann G.M., and Asbury AK. Pathology of the motor-sensory axonal Guillain-Barre. Ann Neurol 39 (1996) 17-28
88. Jung S., Huitinga I., Schmidt B., Zielasek J., Dijkstra C.D., Toyka K.V., and Hartung HP. Selective elimination of macrophages by dichloromethylene diphosphonate-containing liposomes suppresses experimental autoimmune neuritis. J Neurol Sci 119 (1993) 195-202
89. Hartung H.P., Schafer B., van der meide P.H., Fierz W., Heininger K., and Toyka KV. The role of interferon-gamma in the pathogenesis of experimental autoimmune disease of the peripheral nervous system. Ann Neurol 27 (1990) 247-257
90. Weishaupt A., Gold R., Hartung H., Gaupp S., Brück W., and Toyka KV. Role of TNF-α in high-dose antigen therapy in experimental autoimmune neuritis: Inhibition of TNF-α by neutralizing antibodies reduces T-cell apoptosis and prevents liver necrosis. J Neuropathol Exp Neurol 59 (2000) 368-376
91. Zettl U.K., Mix E., Zielasek J., Stangel M., Hartung H.P., and Gold R. Apoptosis of myelin-reactive T cells induced by reactive oxygen and nitrogen intermediates in vitro. Cell Immunol 178 (1997) 1-8
92. Bai X.F., Zhu J., Zhang G.X., Kaponides G., Hojeberg B., van der Meide P.H., and Link H. IL-10 suppresses experimental autoimmune neuritis and down regulates cytokine mRNA expression of Th1 and macrophage source. Clin Immunol Immunopathol 83 (1997) 117-126
93. Kiefer R., Funa K., Schweitzer T., Jung S., Bourde O., Toyka K.V., and Hartung HP. Transforming growth factor-β1 in experimental autoimmune neuritis: Cellular localization and time course. Am J Pathol 148 (1996) 211-223
94. Sindern E., Schweppe K., Ossege L.M., and Mailin JP. Potential role of transforming growth factor-β1 in terminating the immune response in patients with Guillain-Barré syndrome. J Neurol 243 (1996) 264-268
95. Hirata K., Mitoma H., Ueno N., He J.W., and Kawabuchi M. Differential response of macrophage subpopulations to myelin degradation in the injured rat sciatic nerve. J Neurocytol 28 (1999) 685-695
96. Day W.A., Kosihi K., and McLennan IS. Transforming growth factor beta 1 may regulate the stability of mature myelin sheath. Exp Neurol 184 (2003) 857-864
97. Grothe C., Meisinger C., and Claus P. In vivo expression and localization of the fibroblast growth factor system in the intact and lesioned rat peripheral nerve and spinal ganglia. J Comp Neurol 434 (2001) 342-357
98. Oya T., Zhao Y.L., Takagawa K., Kawaguchi M., Shirakawa K., Yamauchi T., and Sasahara M. Platelet-derived growth factor-b expression induced after rat peripheral nerve injuries. Glia 38 (2002) 303-312
99. Reichert F., Levitzky R., and Rothshenker S. Interleukin 6 in intact and injured mouse peripheral nerves. Eur J Neurosci 8 (1996) 530-535
100. Martin R., McFarland H.F., and McFarlin DE. Immunological aspects of demyelinating diseases. Annu Rev Immunol 10 (1992) 153-187
101. Burns J., Rosenzweig A., Zweiman B., and Lisak RP. Isolation of myelin basic protein-reactive T cell lines from normal human blood. Cell Immunol 81 (1983) 435-440
102. Correale J., McMillan M., McCarthy K., Le T., and Weiner LP. Isolation and characterization of autoreactive proteolipid protein-peptide specific T-cell clones from multiple sclerosis patients. Neurology 45 (1995) 1370-1378
103. Bieber A.J., Kerr S., and Rodriguez M. Efficient central nervous system remyelination requires T cells. Ann Neurol 53 (2003) 680-684
104. Yoles E., Hauben E., Palgi O., Agarnov E., Gothilf A., Cohen A., Kuchroo V., Cohen I.R., Weiner H.L., and Schwartz M. Protective autoimmunity is a physiological response to CNS trauma. J Neurosci 21 (2001) 3740-3748
105. Byram S.C., Carson M.J., DeBoy C.A., Serpe C.J., Sanders V.M., and Jones KJ. CD4-positive T cell-mediated neuroprotection requires dual compartment antigen presentation. J Neurosci 24 (2004) 4333-4339
106. Jones K.J., Serpe C.J., Byram S.C., DeBoy C.A., and Sanders VM. Role of the immune system in the maintenance of mouse facial motoneuron viability after nerve injury. Brain Behav Immun 19 (2005) 12-19
107. Kipnis J., Mizrahi T., Hauben E., Shaked I., Shevach E., and Schwartz M. Neuroprotective autoimmunity: Naturally occurring CD4+CD25+ regulatory T cells suppress the ability to withstand injury to the central nervous system. Proc Natl Acad Sci 99 (2002) 15620-15625
108. Chamorro A., and Hallenbeck J. The harms and benefits of inflammatory and immune responses in vascular disease. Stroke 37 (2006) 291-293
109. Frenkel D., Huang Z., Maron R., Koldzic D.N., Hancock W.W., Moskowitz M.A., and Weiner HL. Nasal vaccination with myelin oligodendrocyte glycoprotein reduces stroke size by inducing IL-10-producing CD4+ T cells. J Immunol 172 (2004) 6549-6555
110. Becker K.J., McCArron R.M., Ruetzler C., Laban O., Sternberg E., Flanders K.C., and Hallenbeck JM. Immunologic tolerance to myelin basic protein decreases stroke size after transient focal cerebral ischemia. Proc Natl Acad Sci 94 (1997) 10873-10878
111. Lewitus G.M., Kipnis J., Avidan H., Ben-Nun A., and Schwartz M. Neuroprotection induced by mucosal tolerance is epitope dependent: Conflicting effects in different strains. J Neuroimmunol 175 (2006) 31-38
112. Hauben E., Nevo U., Yoles E., Moaleem G., Agranov E., Mor F., Akselrod S., Neeman M., Cohen I.R., and Schwartz M. Autoimmune T cells as potential neuroprotective therapy for spinal cord injury. Lancet 355 (2000) 286-287
113. Moalem G., Leibowitz-Amit R., Yoles E., Mor F., Cohen I.R., and Schwartz M. Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy. Nature Med 5 (1999) 49-55
114. Schwartz M., and Hauben E. T-cell based therapeutic vaccination for spinal cord injury. Prog Brain Res 137 (2002) 401-406
115. Hauben E., Gothilf A., Cohen A., Butovsky O., Nevo U., Smirnov I., Yoles E., Akselrod S., and Schwartz M. Vaccination with dendritic cells pulsed with peptides of myelin basic protein promotes functional recovery from spinal cord injury. J Neurosci 23 (2003) 8808-8819
116. Correale J B., and Molinas MM. Oligoclonal bands and antibody responses in multiple sclerosis. J Neurol 249 (2002) 375-389
117. Rodriguez M., Lennon V.A., Benveniste E.N., and Merril JE. Remyelination by oligodendrocytes stimulated by antiserum to spinal cord. J Neuropathol Exp Neurol 46 (1987) 84-95
118. Asakura K., Miller D.J., Murray P., Bansal R., Pfeiffer S.E., and Rodriguez M. Monoclonal autoantibody SCH94.03, which promotes central nervous system remyelination, recognizes an antigen on the surface of oligodendrocytes. J Neurosci Res 43 (1996) 273
119. Asakura K., Miller D.J., Pease L.R., and Rodriguez M. Targeting of IgMκ antibodies to oligodendrocytes promotes CNS remyelination. J Neurosci 18 (1998) 7700-7708
120. Bieber A.J., Warrington A., Asakura K., Ciric B., Kaveri S.V., Pease L.R., and Rodriguez M. Human antibodies accelerate the rate of remyelination following lysolecithin-induced demyelination in mice. Glia 37 (2002) 241-249
121. Warrington A.E., Asakura K., Bieber A.J., Ciric B V., Keulen V., Kaveri S.V., Kyle R.A., Pease L.R., and Rodriguez M. Human monoclonal antibodies reactive to oligodendrocytes promote remyelination in a model of multiple sclerosis. Proc Natl Acad Sci 97 (2000) 6820-6825
122. Pirko I., Ciric B., Gamez J., Bieber A.J., Warrington A.E., Johnson A.J., Hanson D.P., Pease L.R., Macura S.I., and Rodriguez M. A human antibody that promotes remyelination enters the CNS and decrease lesion load as detected by T2-weighted spinal cord MRI in a virus-induced murine model of MS. FASEB J 18 (2004) 1577-1579
123. Warrington A.E., Bieber AJ v., Keulen V., Ciric B., Pease L.R., and Rodriguez M. Neuron-binding human monoclonal antibodies support central nervous system neurite extension. J Neuropathol Exp Neurol 63 (2004) 461-473
124. Dyer C.A., and Benjamins JA. Organization of oligodendrocytes membrane sheets. II. Galactocerebroside: Antibody interactions signal changes in cytoskeleton and myelin basic protein. J Neurosci Res 24 (1998) 212-221
125. Dyer C.A., and Matthieu JM. Antibodies to myelin/oligodendrocyte-specific protein and myelin/oligodendrocyte-specific glycoprotein signal distinct changes in the organization of cultured oligodendroglial membranes. J Neurochem 62 (1994) 777-787
126. 2+ responses in oligodendrocytes. J Neurosci Res 30 (1991) 699-711
127. 2+ influx pathways in astrocytes and oligodendrocytes: Relationship to the mechanisms of myelin repair. Moll Cell Neurosci 22 (2003) 14-24
128. DeJong B.A., and Smith ME. A role for complement in phagocytosis of myelin. Neurochem Res 22 (1996) 491-498
129. Kuhlmann T., and Bruck W. Immunoglobulins induced myelin debris clearance by mouse macrophages. Neurosci Lett 19 (1999) 191-194
130. Ciric B., Howe CL P., Soldan M., Warrington A.E., Bieber A.J., van Keulen V., Rodriguez M., and Pease LR. Human monoclonal IgM antibody promotes CNS myelin repair independent of Fc function. Brain Pathol 13 (2003) 608-616
131. Miller D.J., Bright J.J., Sriram S., and Rodriguez M. Successful treatment of established relapsing experimental autoimmune encephalomyelitis in mice with a monoclonal natural antibody. J Neuroimmunol 75 (1997) 204-209
132. Ciric B., Van Keulen V., Paz Soldan M., Rodriguez M., and Pease LR. Antibody-mediated remyelination operates through mechanism independent of immunomodulation. J Neuroimmunol 146 (2004) 153-161
133. Howe C.L., Bieber A.J., Warrington A.E., Pease L.R., and Rodriguez M. Antiapoptotic signalling by a remyelination-promoting human antimyelin antibody. Neurobiol Dis 15 (2004) 120-131
134. Irving E.A., Vinson M., Rosin C., Roberts J.C., Cahpman D.M., Facci L., Virley D.J., Skaper S.D., Burbidge S.A., Walsh F.S., Hunter A.J., and Parsons AA. Identification of neuroprotective properties of anti-MAG antibody: A novel approach for the treatment of stroke?. J Cereb Blood Flow Metab 25 (2005) 98-107
135. Karnezis T., Mandemakers W., McQualter J.L., Zheng B., Ho P.P., Jordan K.A., Murray B.M., Barres B., Tessier-Levigne M., and Bernard CC. The neurite outgrowth inhibitor Nogo A is involved in autoimmune-mediated demyelination. Nat Neurosci 7 (2004) 736-744
136. Mears S., Schachner M., and Brushart TM. Antibodies to myelin-associated glycoprotein accelerate preferential motor reinnervation. J Peripher Nerv Syst 8 (2003) 91-99
137. Banks W.A., and Kastin AJ. Blood to brain transport of interleukin links the immune and central nervous systems. Life Sci 48 (1991) L117-L121
138. Ransohoff R.R., and Benveniste EN. Cytokines and the CNS (1996), CRC Press, Boca Ratón
139. Mohan R., Edwards E.T., Cupps T.R., Oliverio P.J., Sandberg G., Crayton H., Richert J.R., and Siegel JN. Demyelination occurring during anti-tumor necrosis factor alpha therapy for inflammatory arthritis. Arthritis Rheum 44 (2001) 2862-2869
140. Sicotte N.L., and Voskhul RR. Onset of multiple sclerosis associated with anti-TNF therapy. Neurology 57 (2001) 1885-1888
141. The Lenercep Group. TNF neutralization in MS: Results of a randomized placebo-controlled multicenter study. Neurology 53 (1999) 457-465
142. van Oosten B.W., Barkhof F., Truyen L., Boringa J.B., Bertelsmann FW v., Blomberg B.M., Woody J.N., Hartung H.P., and Polman CH. Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2. Neurology 47 (1996) 1531-1534
143. Arnett H.A., Masson J., Marino M., Suzuki K., Matsushima G.K., and Ting JPY. TNFα promotes proliferation of oligodendrocyte progenitors and remyelination. Nat Neurosci 4 (2001) 1116-1122
144. Scherbel U., Raghupathi R., Nakamura M., Saatman K.E., Trojanowski J.Q., Neugebauer E., Marino M.W., and McIntosh TK. Differential acute and chronic responses of tumor necrosis factor-deficient mice to experimental brain injury. Proc Natl Acad Sci 96 (1999) 8721-8726
145. Fontaine V., Mohand-Saine S., Hanoteau N., Fuchs C., Pfizenmaier K., and Eisel U. Neurodegenerative and neuroprotective effects of tumor necrosis factor (TNF) in retinal ischemia: Opposite roles of TNF receptor 1 and TNF receptor 2. J Neurosci 22 (2002) RC216
146. Arnett H.A., Wang Y., Matsushima G.K., Suzuki K., and Ting JPY. Functional genomic analysis of remyelination reveals importance of inflammation in oligodendrocytes regeneration. J Neurosci 23 (2003) 9824-9832
147. Kassiotis G., and Kollias G. Uncoupling the proinflammatory from the immunosuppressive properties of tumor necrosis factor (TNF) at the p55 TNF receptor level: Implications for pathogenesis and therapy of autoimmune demyelination. J Exp Med 193 (2001) 427-434
148. Thommesen L., and Laegreid A. Distinct differences between TNF receptor-1 and TNF receptor2-mediated activation of NFkappaB. J Biochem Mol Biol 38 (2005) 281-289
149. Marchetti L., Klein M., Schletti K., Pfizenmaier K., and Eisel ULM. Tumor necrosis factor (TNF)-mediated neuroprotection against glutamate-induced excitotoxicity is enhanced by N-methyl-d-aspartate receptor activation. J Biol Chem 279 (2004) 32869-32881
150. Bruce A.J., Boling W., Kindy M.S., Peschon J., Kraemer P.J., Carpenter M.K., Holtsberg F.W., and Mattson MP. Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors. Nat Med 2 (1996) 788-794
151. 2+ accumulation. Proc Natl Acad Sci 92 (1995) 9328-9332
152. Cheng B., Christakos S., and Mattson MP. Tumor necrosis factor protects neurons against metabolic-excitotoxic insults and promote maintenance of calcium homeostasis. Neuron 12 (1994) 139-153
153. Masson J.L., Suzuki K., Chaplin D.D., and Matsushima GK. Inteleukin-1β promotes repair of the CNS. J Neurosci 21 (2001) 7046-7052
154. Herx L.M., Rivest S., and Yong VW. Central nervous system-initiated inflammation and neurotrophism in trauma: IL-1β is required for the production of ciliary neurotrophic factor. J Immunol 165 (2000) 2232-2239
155. DeKosky S.T., Styren S.D., O'Malley M.E., Gross J.R., Kochanek P., Marion D., Evans C.H., and Robbins PD. Interleukin-1 receptor antagonists suppresses neurotrophin response in injured rat brain. Ann Neurol 39 (1996) 123-127
156. Bernardino L., Xapelli L., Silva A.P., Jakobsen B., Poulsen F.R., Oliveira C.R., Vezzani A., Malva J.O., and Zimmer J. Modulator effects of interleukin-1β and tumor necrosis factor-α on AMPA-induced excitotoxicity in mouse organotypic hippocampal slice cultures. J Neurosci 25 (2005) 6734-6744
157. Lindholm D., Heumann R., Meyer M., and Thoenen H. Interleukin-1 regulates synthesis of nerve growth factor in non-neuronal cells of rat sciatic nerve. Nature 330 (1987) 658-659
158. Billiau A., Heremans H., Vandekerckhove F., Dijkmans R., Sobis H., Meulepas E., and Carton H. Enhancement of experimental allergic encephalomyelitis in mice by antibodies against IFN-gamma. J Immunol 140 (1988) 1506-1510
159. Duong TT S., Louis J., Gilbert J.J., Finkelman F.D., and Strejan GH. Effect of anti-interferon gamma and anti-interleukin-2 monoclonal antibody treatment on the development of actively and passively induced experimental allergic encephalomyelitis in the SJL/J mouse. J Neuroimmunol 36 (1992) 105-115
160. Willenborg D.O., Fordham S., Bernard C.C., Cowden W.B., and Ramshaw IA. IFN-gamma plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. J Immunol 157 (1996) 3223-3227
161. Furlan R., Brambilla E., Ruffini F., Poliani P.L., Bergami A., Marconi P.C., Franciotta D.M., Penna G., Comi G., Adorini L., and Martino G. Intrathecal delivery of IFN-gamma protects C57BL/6 mice from chronic-progressive experimental autoimmune encephalomyelitis by increasing apoptosis of central nervous system-infiltrating lymphocytes. J Immunol 167 (2001) 1821-1829
162. Alexander W.S., Starr R., Fenner J.E., Scott C.L., Handmann E., Sprigg N.S., Corbin J.E., Cornish A.L., Darwiche R., Owczareck C.M., Kay T.W., Nicola N.A., Hertzog P.J., Metclaf D., and Hilton DJ. SOCS1 is a critical inhibitor of interferon gamma signalling and prevents the potentially fatal neonatal actions of this cytokine. Cell 98 (1999) 597-608
163. Marine J.C., Topham D.J., McKay C., Wang D., Parganas E., Stravopodis E., Yoshimura A., and Ihle JN. SOCS1 deficiency causes a lymphocyte-dependent perinatal lethality. Cell 98 (1999) 609-616
164. Panitch H.S., Hirsch R.L., Schindler J., and Johnson KP. Treatment of multiple sclerosis with gamma interferon: Exacerbations associated with activation of the immune system. Neurology 37 (1987) 1097-1102
165. Gruol D.L., and Nelson TE. Physiological and pathological roles of interleukin-6 in the central nervous system. Mol Neurobiol 15 (1997) 307-339
166. Carlson N.G., Wieggel W.A., Chen A., Bachi A., Rogers S.W., and Gahring LC. Inflammatory cytokines IL-1α, IL-1β, IL-6, and TNF-α impart neuroprotection to an excitotoxin through distinct pathways. J Immunol 163 (1999) 3963-3968
167. Yamashita T., Sawamoto K., Suzuki S., Suzuki N., Adachi K., Kawase T., Mihara M., Ohsugi Y., Abe K., and Okano H. Blockade of interleukin-6 signaling aggravates ischemic cerebral damage in mice: Possible involvement of Stat3 activation in the protection of neurons. J Neurochem 94 (2005) 459-468
168. Herrmann O., Tarabin V., Suzuki S., Attigah N., Coserea I., Schneider A., Vogel J., Prinz S., Schwab S., Monyer H., Brombacher F., and Schwaninger M. Regulation of body temperature and neuroprotection by endogenous interleukin-6 in cerebral ischemia. J Cereb Blood Flow Metab 23 (2003) 406-415
169. Penkowa M., Penkowa M., Moos T., Carrasco J., Hadberg H., Molinero A., Bluethmann H., and Hidalgo J. Strongly compromised inflammatory response to brain injury in interleukin-6 deficient mice. Glia 25 (1999) 343-357
170. Clark W.M., Rinker L.G., Lessov N.S., Hazel K., Hill J.K., Stenzel-Poore M., and Eckenstein F. Lack of interelukin-6 expression is not protective against focal central nervous system ischemia. Stroke 31 (2000) 1715-1720
171. Hao A.J., Dheen S.T., and Ling EA. Expression of macrophage colony-stimulating factor and its receptor in microglia activation is linked to teratogen-induced neuronal damage. Neuroscience 112 (2002) 889-900
172. Vincent V.A., Robinson C.C., Simsek D., and Murphy GM. Macrophage colony stimulating factor prevents NMDA-induced neuronal death in hippocampal organotypic cultures. J Neurochem 82 (2002) 1388-1397
173. Wang Y., Berezovskaya O., and Fedoroff S. Expression of colony stimulating factor-1 receptor (CSF-1R) by CNS neurons in mice. J Neurosci Res 57 (1999) 616-632
174. Mitrasinovic O.M., Grattan A., Robinson C.C., Lapustea N.B., Poon C., Ryan H., Pong C., and Murphy GM. Microglia overexpressing the macrophage colony-stimulating factor receptor are neuroprotective in a microglial-hippocampal organotypic coculture system. J Neurosci 25 (2005) 4442-4451
175. Berezovskaya O., Maysinger D., and Fedoroff S. The hematopoietic cytokine colony- stimulating factor1, is also a growth factor in the CNS: Congenital absence of CSF-1 in mice results in abnormal microglial response and increased neuron vulnerability to injury. Int J Dev Neurosci 13 (1995) 285-299
176. Fedoroff S., Berezovskaya O., and Maysinger D. Role of colony stimulating factor-1 in brain damage caused by ischemia. Neurosci Biobehav Rev 21 (1997) 187-191
177. Berezovskaya O., Maysinger D., and Fedoroff S. Colony stimulating factor-1 potentiates neuronal survival in cerebral cortex ischemic lesion. Acta Neuropathol (Berl) 92 (1996) 479-486
178. Guillen C., Jander S., and Stoll G. Sequential expression of mRNA for proinflammatory cytokines and interleukin-10 in the rat peripheral nervous system: Comparison between immune-mediated demyelination and Wallerian degeneration. J Neurosci Res 51 (1998) 489-496
179. Rotshenker S., Aamar S., and Barak V. Interleukin-1 activity in lesioned peripheral nerve. J Neuroimmunol 39 (1992) 75-80
180. Stoll G., Jung S., Van der Meide P., and Hartung HP. Tumor necrosis factor-alpha in immune mediated demyelination and Wallerian degeneration of the peripheral nervous system. J Neuroimmunol 45 (1993) 175-182
181. Wagner R., and Myers RR. Schwann cells produce tumor necrosis factor alpha: Expression in injured and noninjured nerves. Neuroscience 73 (1996) 625-629
182. Heumann R., Korsching S., Bandtlow C., and Thoenen H. Changes of nerve growth factor synthesis in non neuronal cells response to sciatic nerve transection. J Cell Biol 104 (1987) 1623-1631
183. Hattori A., Iwasaki S., Murase K., Tsujimoto M., Sato M., Hayashi K., and Khono M. Tumor necrosis factor is markedly synergistic with interleukin 1 and interferon-γ in stimulating the production of nerve growth factor in fibroblasts. FEBS Lett 340 (1994) 177-180
184. Lisak R.P., Bealmer B., and Ragheb S. Interleukin-1 alpha, but not interleukin 1-beta, is a co-mitogen for neonatal rat Schwann cells in vitro and acts via interleukin-1 receptors. J Neuroimmunol 55 (1994) 171-177
185. Guenard V., Dinarello C.A., Weston P.J., and Aebischer P. Peripheral nerve regeneration is impeded by interleukin-1 receptor antagonist released from a polymeric guidance channel. J Neurosci Res 29 (1991) 396-400
186. Saada A., Reichert F., and Rotshenker S. Granulocyte macrophage colony stimulating factor produced in lesioned peripheral nerves induces the up-regulation of cell surface expression of MAC-2 by macrophages and Schwann cells. J Cell Biol 133 (1996) 159-167
187. Be′aeri H., Reichert F., Saada A., and Rotshenker S. The cytokine network of Wallerian degeneration: IL-10 and GM-CSF. Eur J Neurosci 10 (1998) 2707-2713
188. Kerscheinsteiner M., Stadelmann C., Dechant G., Wekerle H., and Hohlfeld R. Neurotrophic cross-talk between the nervous and immune systems: Implications for neurological diseases. Ann Neurol 53 (2003) 292-304
189. Barde Y.A., Edgar D., and Thoenen H. New neurotrophic factors. Annu Rev Physiol 45 (1983) 601-612
190. Lewin G.R., and Barde YA. Physiology of the neurotrophins. Annu Rev Neurosci 19 (1996) 289-317
191. Baloh R.H., Enomoto H., Johnson Jr. E.M., and Milbrandt J. The GDNF family ligands and receptors - Implications for neural development. Curr Opin Neurobiol 10 (2000) 103-110
192. Ip NY. The neurotrophins and neuropoietic cytokines. Two families of growth factors acting on neural and hematopoietic cells. Ann N Y Acad Sci 840 (1998) 97-106
193. Ransohoff R.M., and Howe CL R.M. Growth factor treatment of demyelinating disease: At last, a leap into the light. Trends Immunol 23 (2002) 512-516
194. Barouch R., Appel E., Kazimirsky G., and Brodie C. Macrophages express neurotrophins and neurotrophin receptors. Regulation of nitric oxide production by NT-3. J Neuroimmunol 112 (2001) 72-77
195. Besser M., and Wang R. Clonally restricted production of the neurotrophin brain-derived neurotrophic factor and neurotrophin-3 mRNA by human immune cells and Th1/Th2-polarized expression of their receptors. J Immunol 162 (1999) 6303-6306
196. Ehrhard P.B., Erb P., Garumann U., and Otten U. Expression of nerve growth factor and nerve growth factor receptor tyrosine kinase Trk in activated CD4-positive T cell clones. Proc Natl Acad Sci USA 90 (1993) 10984-10988
197. Kerscheinsteiner M., Gallmeier E., Behrens L V., Leal V., Misgeld T., Klinkert W., Kolbeck R., Hoppe E., Oropeza-Wekerle R., Bartke I., Stadelmann C., Lassmann H., Wekerle H., and Hohlfeld R. Activated human T cells, B cells and monocytes produced brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: A neuroprotective role of inflammation?. J Exp Med 189 (1999) 865-870
198. Santambrogio L., Benedetti M., Caho M.V., Muzaffar R., Kulig K., Gabell N., and Hochwald G. Nerve growth factor production by lymphocytes. J Immunol 153 (1994) 4488-4495
199. Torcia M., Bracci-Laudiero L., Lucibello M., Nencioni L., Labardi D., Rubartelli A., Cozzolino F., Aloe L., and Garaci E. Nerve growth factor is an autocrine survival factor for memory B lymphocytes. Cell 85 (1996) 345-356
200. Moalen G., Gdalyahu A., Shani Y., Otten U., Lazarovici P., Cohen I.R., and Schwarz M. Production of neurotrophins by activated T cells: Implications for neuroprotective autoimmunity. J Autoimmun 15 (2000) 331-345
201. Micera A., De Simone R., and Aloe L. Elevated levels of nerve growth factor in the thalamus and spinal cord of rats affected by experimental allergic encephalomyelitis. Arch Ital Biol 133 (1995) 131-142
202. Hammarberg H., Lidman O., Lundberg C., Eltayeb S.Y., Gielen A.W., Muhallab S., Svenningsson A., Linda H., van Der Meide P.H., Cullheim S., Olsson T., and Piehl F. Neuroprotection by encephalomyelitis: Rescue of mechanically injured neurons and neurotrophin production by CNS-infiltrating T and natural killer cells. J Neurosci 20 (2000) 5283-5291
203. Stadelmann C., Kerschensteiner M., Misgeld T., Brück W., Hohlfeld R., and Lassmann H. BDNF and gp145trkB in multiple sclerosis brain lesions: Neuroprotective interactions between immune and neuronal cells?. Brain 125 (2002) 75-85
204. Flugel A., Matsumuro K., Neumann H., Klinkert W.E., Birnbacher R., Lassmann H., Otten U., and Wekerle H. Anti-inflammatory activity of nerve growth factor in experimental autoimmune encephalomyelitis inhibition of monocyte trans-endothelial migration. Eur J Immunol 31 (2001) 11-22
205. Lambiase A., Bracci-Laudiero L., Bonini S., Bonini S., Starace G D., Elios MM D., Carli M., and Aloe L. Human CD4+ T cell clones produce and release nerve growth factor and express high-affinity nerve growth factor receptors. J Allergy Clin Immunol 100 (1997) 408-414
206. Melamed I., Kelleher C.A., Franklin R.A., Brodie C., Hempstead B., Kaplan D., and Gelfand EW. Nerve growth signal transduction in human B lymphocytes is mediated by gp 140trk. Eur J Immunol 26 (1996) 1985-1992
207. Neumann H., Misgeld T., Matsumuro K., and Wekerle H. Neurotrophins inhibit major histocompatibility class II inducibility of microglia: Involvement of the p75 neurotrophin receptor. Proc Natl Acad Sci 95 (1998) 5779-5784
208. Otten U., Ehrhard P., and Peck E. Nerve growth factor induces growth and differentiation of human B lymphocytes. Proc Natl Acad Sci 86 (1989) 10059-10063
209. Thorpe L.W., and Perez-Polo JR. The influence of nerve growth factor on in vitro proliferative response of rat spleen lymphocytes. J Neurosci Res 18 (1987) 134-139
210. Villoslada P., Hauser S.L., Bartke I., Unger J., Heald N., Rosenberg D., Cheung S.W., Mobley W.C., Fisher S., and Genain CP. Human nerve growth factor protects common marmosets against autoimmune encephalomyelitis by switching the balance of T helper cell type 1 and 2 cytokines within the central nervous system. J Exp Med 191 (2000) 1799-1806
211. Wei R., and Jonakait GM. Neurotrophins and the anti-inflammatory agents interleukin-4 (IL-4), IL-10, IL-11 and transforming growth factor beta-1 (TGF-beta 1) down-regulate T cell costimulatory molecules B7 and CD40 on cultured rat microglia. J Neuroimmunol 95 (1999) 8-18
212. Villoslada P., and Genain CP. Role of nerve growth factor and other trophic factors in brain inflammation. Prog Brain Res 146 (2004) 403-414
213. Vanderlocht J., Hellings N., Hendriks J.J., Vandenabeele F., Moreels M., Buntinx M., Hoekstra D., Antel J.P., and Stinissen P. Leukemia inhibitory factor is produced by myelin-reactive T cells from multiple sclerosis patients and protects against tumor-necrosis factor-induced oligodendrocyte apoptosis. J Nuerosci Res 83 (2006) 763-774
214. Butzkueven H., Zhang J.G., Soilu-Hanninen M., Hochrein H., Chionh F., Shipham K.A., Emery B., Turnley A.M., Petratos S., Ernst M., Bartlett P.F., and Kilpatrick TJ. LIF receptor signaling limits immune-mediated demyelination by enhancing oligodendrocyte survival. Nat Med 8 (2002) 613-619
215. Linker R.A., Maurer M., Gaupp S., Martini R., Holtmann B., Giess R., Rieckmann P., Lassmann H., Toyka K.V., Sendtner M., and Gold R. CNTF is a major protective factor in demyelinating CNS disease: A neurotrophic cytokine as modulator in neuroinflammation. Nat Med 8 (2002) 620-624
216. Albrecht P.J., Dahl J.P., Stoltzfus O.K., Levenson R., and Levinson SW. Ciliary neurotrophic factor activates spinal cord astrocytes, stimulating their production and release of fibroblast growth factor-2, to increase motor neuron survival. Exp Neurol 173 (2002) 46-62
217. Batchelor P.E., Liberatore G.T., Wong J., Porrit M.J., Frerichs F., Donnan G.A., and Howells DW. Activated macrophages and microglia induce dopaminergic sprouting in the injured striatum and express brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor. J Neurosci 19 (1999) 1708-1716
218. Hammarberg H., Lidman O., Lundberg C., Eltayeb S.Y., Gielen A.W., Muhallab S., Lindå H., Svenningsson A., van der Meide P.H., Culheim S., Olsson T., and Piehl F. Neuroprotection by encephalomyelitis: Rescue of mechanically injured neurons and neurotrophin production by CNS-infiltrating T and natural killer cells. J Neurosci 20 (2000) 5283-5291
219. Linker RA M., urer M., Gaupp S., Martini R., Holtmann B., Giess R., Rieckmann P., Lassman H., Toyka K.V., Sendtner M., and Gold R. CNTF is a major protective factor in demyelinating CNS disease: A neurotrophic cytokine as modulator in neuroinflammation. Nature Med 8 (2002) 620-624
220. Sobue G., Yamamoto M., Doyu M., Li M., Yasuda T., and Mitsuma T. Expression of mRNA for neurotrophins (NGF, BDNF, and NT-3) and their receptors (p75NGFR, trkB, and trkC) in human peripheral neuropathies. Neurochem Res 23 (1998) 821-829
221. Yao D.L., Liu X., Hudson L.D., and Webster HD. Insulin-like growth factor I treatment reduces demyelination and up-regulates gene expression of myelin-related proteins in experimental autoimmune encephalomyelitis. Proc Natl Acad Sci USA 92 (1995) 6190-6194
222. Barouch R., and Schwartz M. Autoreactive T cells induce neurotrophin production by immune and neural cells in injured rat optic nerve: Implications for protective autoimmunity. FASEB J 16 (2002) 1304-1306
223. Nye S.H., Squinto S.P., Glass D.J., Stitt T.N., Hantzopoulos P., Macchi M.J., Lindsay N.S., Ip N.Y., and Yancopoulos GD. K-252a and staurosporine selectively block autophosphorylation of neurotrophin receptors and neurotrophin-mediated responses. Mol Biol Cell 3 (1992) 677-686